China's 1st COVID-19 recombinant subunit vaccines begin phase-III trials domestically

By Global Times Published: Nov 19, 2020 12:22 PM

vaccine Photo:VCG

Phase-III trials involving China's COVID-19 recombinant subunit vaccines were launched on Wed in East China's Anhui Province, becoming the first candidate of such kind to start phase-III trials domestically.